In a post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Julie Bines, a pediatric gastroenterologist heading the Rotavirus Vaccine Program for RV3 at the Murdoch Children’s Research Institute (MCRI), the University of Melbourne and Royal Children’s Hospital, reports on efforts to develop a rotavirus vaccine for newborns, writing, “Working together with the teams from the Universitas Gadjah Mada and Bio Farma, the Indonesian vaccine manufacturer, as part of the RV3 Rotavirus Vaccine Program, we are studying an innovative rotavirus vaccine that could save thousands.” Noting “[r]otavirus is the most common cause of severe diarrhea,” she describes efforts to control the spread of rotavirus globally, highlighting two existing vaccines, and continues, “The goal of the RV3 Rotavirus Vaccine Program is to develop a safe, effective, affordable vaccine aimed at preventing rotavirus diarrhea from birth” (8/21).